Welcome to CDC Stacks | Recommendations for early empiric antiviral treatment in persons with suspected influenza who are at increased risk of developing severe disease - 25210 | Health Alert Network (HAN)
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Recommendations for early empiric antiviral treatment in persons with suspected influenza who are at increased risk of developing severe disease
  • Published Date:
    10/19/09
  • Source:
    HAN ; 299
  • Language:
    English
Filetype[PDF - 746.49 KB]


Details:
  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
  • Keywords:
  • Series:
    HAN ; 299
  • Document Type:
    HAN Health Advisory
  • Collection(s):
    Health Alert Network (HAN)
  • Description:
    Monday, October 19, 2009, 13:51 EDT (1:51 PM EDT)

    CDCHAN-00299-2009-10-19-ADV-N

    Summary Recommendations: When treatment of influenza is indicated in a patient with suspected influenza, health care providers should initiate empiric antiviral treatment as soon as possible. Waiting for laboratory confirmation of influenza to begin treatment with antiviral drugs is not necessary. Patients with a negative rapid influenza diagnostic test should be considered for treatment if clinically indicated because a negative rapid influenza test result does not rule out influenza virus infection. The sensitivity of rapid influenza diagnostic tests for 2009 H1N1 virus can range from 10% to 70%, indicating that false negative results occur frequently.

  • Supporting Files:
    No Additional Files
No Related Documents.